(NASDAQ:MDXG), MARIETTA, Ga., Nov. 03, 2025 (GLOBE NEWSWIRE) — MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today commented on the Centers for Medicare and Medicaid Services (“CMS”) release of the CY 2026 Physician Fee Schedule (“PFS”) final rule, which was published on Friday. “Over the last several years, we have actively engaged with […]

Milford, CT, Nov. 03, 2025 (GLOBE NEWSWIRE) — Preshent announced new momentum in advancing its intelligent sustainability ecosystem, a unified framework merging artificial intelligence, blockchain, and infrastructure innovation to accelerate the world's transition toward a data-driven transformative economy. Preshent has secured several multimillion-dollar renewable infrastructure initiatives with Tribal Nations across the Rio Grande Valley and

(Euronext Growth Paris:ALCLS),(NasdaqGM:CLLS), Preliminary data recently shared for eti-cel (UCART20x22) show an 86% ORR and a 57% CR rate (n=7), underscoring its potential to improve outcomes in r/r NHL Preclinical data demonstrated that combining eti-cel with low-dose IL-2 may deepen and extend anti-tumor activity in patients with r/r NHL Eti-cel full Phase 1 dataset, including

(NASDAQ:IDAI), Atlanta, GA, Nov. 03, 2025 (GLOBE NEWSWIRE) — Trust Stamp (Nasdaq: IDAI): In the wake of recent announcements that the Company has raised in excess of $10M in new capital, the Company announced a cryptocurrency and asset tokenization focused initiative including the biometrically validated, quantum-secure TSI Wallet that can serve as both a non-custodial

(NASDAQ:MRKR), Ongoing Phase 1 APOLLO study investigating MT-601 in patients with relapsed B cell lymphomas showed encouraging preliminary efficacy data MT-601 demonstrated robust safety profile with no dose limiting toxicities (DLTs) or immune-effector cell associated neurotoxicity syndrome (ICANS) in the dose escalation cohort HOUSTON, Nov. 03, 2025 (GLOBE NEWSWIRE) — Marker Therapeutics, Inc. (Nasdaq: MRKR),

(NASDAQ:CAPR), -Publication highlights Deramiocel's anti-fibrotic activity and describes a validated potency assay supporting quality control and product consistency in late-stage development- SAN DIEGO, Nov. 03, 2025 (GLOBE NEWSWIRE) — Capricor Therapeutics, Inc. (NASDAQ: CAPR), a biotechnology company developing cell and exosome-based therapies for rare diseases, today announced the publication in Biomedicines, an international peer-reviewed journal,

(NASDAQ:BYND), EL SEGUNDO, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) — Beyond Meat, Inc. (NASDAQ: BYND), a leader in plant-based meat, today announced the launch of its all-new Beyond Beef 2-Pack at retailers across Canada, making the latest version of its plant-based ground beef product more accessible to consumers. The value pack is rolling into major

(NASDAQ:WTO), SHENZHEN, China, Nov. 03, 2025 (GLOBE NEWSWIRE) — UTime Limited (Nasdaq: WTO) today outlined its ongoing exploration in the field of health data analysis, particularly the potential application of artificial intelligence (AI) technologies. UTime is developing AI-based algorithm models aimed at performing in-depth analysis of continuous physiological data collected from smart wearable devices such

Diana Shipping Inc. Announces Time Charter Contract for m/v Los Angeles with MOL and Direct Continuation of Time Charter Contract for m/v DSI Aquarius with Bunge GlobeNewswire November 03, 2025 ATHENS, Greece, Nov. 03, 2025 (GLOBE NEWSWIRE) — Diana Shipping Inc. (NYSE: DSX), (the “Company”), a global shipping company specializing in the ownership and bareboat

MIMEDX Comments on CY 2026 Medicare Physician Fee Schedule Final Rule Company is Well Positioned to Continue to Compete and Grow GlobeNewswire November 03, 2025 MARIETTA, Ga., Nov. 03, 2025 (GLOBE NEWSWIRE) — MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today commented on the Centers for Medicare and Medicaid Services (“CMS”) release of